Journal of Diagnostics Concepts & Practice >
Correlation between severe coronary stenosis and recurrence after atrial fibrillation cryoablation
Received date: 2025-01-03
Accepted date: 2025-04-07
Online published: 2025-06-25
Objective To investigate the correlation between severe coronary stenosis detected by coronary CT angio-graphy (CCTA) before cryoablation and atrial fibrillation (AF) recurrence. Methods From January 2021 to November 2022, 613 consecutive patients with symptomatic paroxysmal or persistent AF undergoing first-time cryoablation and successful preprocedural CCTA screening were enrolled. Severe coronary stenosis on CCTA was defined as >70% stenosis in at least one major coronary vessel. Patients were divided into two groups: severe stenosis group (n=53) and non-severe stenosis group (n=560). All patients were regularly followed up after ablation to observe safety endpoints such as AF recurrence and surgical complications. Kaplan-Meier analysis was used to assess AF-free survival rate, and multivariate Cox regression was performed to identify predictors of AF recurrence. Results 22.5% of patients were diagnosed with coronary heart disea-se (CHD), of whom 8.6% (53/560) had severe stenosis on pre-ablation CCTA. Compared to the non-severe stenosis group, the severe coronary stenosis group had higher age [(69.6±10.3) years vs. (62.3±11.9) years], higher prevalence of persistent AF (59.3% vs. 31.6%), higher CHA2DS2 -VASc score (2.3±1.6 vs. 1.5±1.4), lower left ventricular ejection fraction (LVEF) [(48.8%±10.3%) vs. (57.2%±8.9%)], higher left atrial volume index (LAVI) [(50.3±11.7) mL/m² vs. (37.0±12.3) mL/m²], and higher E/A ratio (1.6±0.4 vs. 1.1±0.5) (all P<0.05). Among the 53 patients with severe stenosis detected by CCTA, 50 (94.3%) were newly diagnosed with CHD. After a median follow-up of 28 months, the AF recurrence rate was 20.1% (123/613). The severe stenosis group showed an AF recurrence rate of 35.8% (19/53), significantly higher than the 18.6% (104/560) in the non-severe stenosis group (P<0.05). There was no statistically significant difference in the safety endpoint between the two groups (P>0.05). Kaplan-Meier analysis showed lower AF-free survival rate in the severe stenosis group (71.6% vs. 84.8%, P=0.039). Multivariate Cox regression identified age (OR=1.20, 95%CI: 1.09-1.39, P=0.033), persistent AF (OR=2.750, 95%CI: 1.64-5.37, P=0.001), and LAVI (OR=1.14, 95%CI: 1.10-1.38, P=0.008) as independent predictors of AF recurrence. Conclusions Patients with severe coronary stenosis before ablation screening have lower AF-free survival rate, but severe coronary stenosis itself is not an independent predictor of AF recurrence after cryoablation.
LUO Xiaoying , DONG Fengwei , XU Yan , WU Liqun , QI Wenhang . Correlation between severe coronary stenosis and recurrence after atrial fibrillation cryoablation[J]. Journal of Diagnostics Concepts & Practice, 2025 , 24(03) : 328 -332 . DOI: 10.16150/j.1671-2870.2025.03.012
| [1] | SALEH K, HALDAR S. Atrial fibrillation: a contemporary update[J]. Clin Med (Lond), 2023, 23(5):437-441. |
| [2] | BAMAN J R, PASSMAN R S. Atrial fibrillation[J]. JAMA, 2021, 325(21):2218. |
| [3] | ANDRADE J G, WAZNI O M, KUNISS M, et al. Cryoballoon ablation as initial treatment for atrial fibrillation: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2021, 78(9):914-930. |
| [4] | ARYANA A, CHIERCHIA G B, DE ASMUNDIS C. Recurrent atrial fibrillation after cryoballoon ablation: what to expect![J]. Card Electrophysiol Clin, 2020, 12(2):199-208. |
| [5] | ERHARD N, METZNER A, FINK T. Late arrhythmia recurrence after atrial fibrillation ablation: incidence, mechanisms and clinical implications[J]. Herzschrittmacherther Elektrophysiol, 2022, 33(1):71-76. |
| [6] | MOHANTY S, DELLA ROCCA D G, GIANNI C, et al. Predictors of recurrent atrial fibrillation following cathe-ter ablation[J]. Expert Rev Cardiovasc Ther, 2021, 19(3):237-246. |
| [7] | LIANG F, WANG Y. Coronary heart disease and atrial fibrillation: a vicious cycle[J]. Am J Physiol Heart Circ Physiol, 2021, 320(1):H1-H12. |
| [8] | MEKHAEL M, MARROUCHE N, HAJJAR A H E, et al. The relationship between atrial fibrillation and coronary artery disease: Understanding common denominators[J]. Trends Cardiovasc Med, 2024, 34(2):91-98. |
| [9] | CADEMARTIRI F, CASOLO G, CLEMENTE A, et al. Coronary CT angiography: a guide to examination, interpretation, and clinical indications[J]. Expert Rev Cardiovasc Ther, 2021, 19(5):413-425. |
| [10] | GRABY J, KHAVANDI A, THOMPSON D, et al. CT coronary angiography-guided cardiovascular risk scree-ning in asymptomatic patients: is it time?[J]. Clin Radiol, 2021, 76(11):801-811. |
| [11] | JOGLAR J A, CHUNG M K, ARMBRUSTER A L, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines[J]. Circulation, 2024, 149(1):e1-e156. |
| [12] | 中华医学会心血管病学分会, 中国生物医学工程学会心律分会. 心房颤动诊断和治疗中国指南[J]. 中华心血管病杂志, 2023, 51(6),572-618. |
| Chinese Society of Cardiology, Heart Rhythm Committee of Chinese Society of Biomedical Engineering. Chinese guidelines on diagnosis and management of atrial fibrillation[J]. Chin J Card, 2023, 51(6):572-618. | |
| [13] | ROTTLANDER D, SAAL M, DEGEN H, et al. Diagnostic role of coronary CT angiography in paroxysmal or first diagnosed atrial fibrillation[J]. Open Heart, 2021, 8(1):e001638. |
| [14] | PAN Y, HUANG Q, ZHU Y, et al. Diagnosis of coronary artery disease in patients with atrial fibrillation using low tube voltage coronary CT angiography with isotonic low-concentration contrast agent[J]. Int J Cardiovasc Imaging, 2019, 35(12):2239-2248. |
| [15] | WILLIAMS M C, KWIECINSKI J, DORIS M, et al. Low-Attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART)[J]. Circulation, 2020, 141(18):1452-1462. |
| [16] | ZINK M D, CHUA W, ZEEMERING S, et al. Predictors of recurrence of atrial fibrillation within the first 3 months after ablation[J]. Europace, 2020, 22(9):1337-1344. |
| [17] | GUO F, LI C, CHEN C, et al. Impact of coronary artery disease on the outcomes of catheter ablation in patients with atrial fibrillation[J]. Braz J Cardiovasc Surg, 2023, 38(3):381-388. |
| [18] | HIRAYA D, SATO A, HOSHI T, et al. Impact of coronary artery disease and revascularization on recurrence of atrial fibrillation after catheter ablation: Importance of ischemia in managing atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2019, 30(9):1491-1498. |
| [19] | 罗晓颖, 权薇薇, 许燕, 等. C反应蛋白与房颤冷冻球囊导管消融术后房颤复发的相关性研究[J]. 诊断学理论与实践, 2015, 14(3):219-222. |
| LUO X Y, QUAN W W, XU Y, et al. Relationship between C-reactive protein and atrial fibrillation recurrence after cryoballoon ablation[J]. J Diagn Concepts Pract, 2015, 14(3):219-222. |
/
| 〈 |
|
〉 |